These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12010368)

  • 1. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
    Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
    Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
    Terada T; Nakanuma Y
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Nakopoulou L; Stefanaki K; Vourlakou C; Manolaki N; Gakiopoulou H; Michalopoulos G
    Pathol Res Pract; 1999; 195(1):19-24. PubMed ID: 10048090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of proliferating biliary epithelial cells in human liver disease using a monoclonal antibody against DNA polymerase alpha.
    Seki S; Sakaguchi H; Kawakita N; Yanai A; Kuroki T; Kobayashi K
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):133-43. PubMed ID: 7682020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of tumor marker levels in cystic fluid of benign liver cysts.
    Iwase K; Takenaka H; Oshima S; Yagura A; Nishimura Y; Yoshidome K; Tanaka T
    Dig Dis Sci; 1992 Nov; 37(11):1648-54. PubMed ID: 1385056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma.
    Machinami R; Oono Y
    Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):111-8. PubMed ID: 2827370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Lake-Bakaar G; Mazzoccoli V; Ruffini L
    Dig Dis Sci; 2002 Jul; 47(7):1644-8. PubMed ID: 12141830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
    Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
    Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
    Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
    Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.
    Maestranzi S; Przemioslo R; Mitchell H; Sherwood RA
    Ann Clin Biochem; 1998 Jan; 35 ( Pt 1)():99-103. PubMed ID: 9463746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung.
    Ohshio G; Yamaki K; Imamura T; Suwa H; Chang CY; Wada H; Sueno Y; Imamura M
    Tumori; 1995; 81(1):67-73. PubMed ID: 7754546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues.
    Nakajima T; Kagawa K; Ueda K; Ohkawara T; Kimura H; Kakusui M; Deguchi T; Okanoue T; Kashima K; Ashihara T
    J Gastroenterol; 1994 Aug; 29(4):450-4. PubMed ID: 7951855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of proliferating cell nuclear antigen in autoimmune hepatitis in a patient with raised serum concentration of CA19-9.
    Sohda T; Iwata Y; Shijo H; Egashira Y; Egashira K; Okumura M
    J Clin Pathol; 1998 Feb; 51(2):167-9. PubMed ID: 9602695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an oncofetal antigen (DU-PAN-2) in sera of patients with non-malignant hepatobiliary diseases and hepatomas.
    Haviland AE; Borowitz MJ; Killenberg PG; Lan MS; Metzgar RS
    Int J Cancer; 1988 Jun; 41(6):789-93. PubMed ID: 2836318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis.
    Tajiri T; Tate G; Kunimura T; Endo Y; Inoue K; Mitsuya T; Morohoshi T; Yoshiba M
    Dig Dis Sci; 2005 Jan; 50(1):188-95. PubMed ID: 15712659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
    Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.